A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
about
Acellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Rediscovering PertussisRoads to the development of improved pertussis vaccines paved by immunologyPertussis vaccine trials in the 1990sDirected evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.Pertussis: Microbiology, Disease, Treatment, and Prevention.Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.How to make sense of pertussis immunogenicity data.Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.Pertussis immunization for adolescents: What are we waiting for?Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolatesImmunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adultsImmunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV)Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.Th17 cytokines and vaccine-induced immunity.Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.Diagnosis and management of pertussis.Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programsAnalysis of Bordetella pertussis populations in European countries with different vaccination policiesProtective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelEvaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in SenegalComparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussisHumoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.Acellular pertussis vaccines and the role of pertactin and fimbriae.Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response.Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
P2860
Q24193554-2C00FC63-4AFE-427E-A2F3-7444F1CAFA2DQ24201103-3D1B6F2C-5B67-42DF-AB5C-E4BE7751EC48Q24234899-B1B16885-5461-400F-9CC1-470DFCCF6C07Q24243261-23287466-B552-4748-A3B4-FB91FD928474Q24522458-AD1520EC-B4DB-4244-8502-0C20D3A3B009Q26744793-5335C6DB-A99C-448F-9801-BB5E53DEFBF2Q26782939-B8CAF0BD-029D-4C02-986B-FC6E52221516Q27025393-CD572317-8F56-470C-93AD-5E293EC55200Q30155406-69E7BCA1-358C-449D-8648-24DDA4255279Q30251684-A914373A-452D-4341-B858-EB07027A9943Q30656264-BA3D6AA5-5986-4235-BF6F-DDCF78A698BCQ30665598-B6643EEF-1948-4588-BE87-98C20077E3B6Q31083435-711EAD79-593F-4268-85D1-9F32E8391418Q33521111-44F7966A-505D-444F-9B65-55D30DF0BB24Q33582687-699CC98B-CD40-4776-B56C-85B414403789Q33642326-ED48D459-5979-4508-BEF1-3BE2B94F4B4AQ33661613-923AB1B9-8098-488A-BF12-0A4B5ED10A23Q33738499-3544ADE0-E797-4B6F-8E08-727467D4E331Q33749729-EB80A63E-63CB-4A04-8153-FC3E5C522E57Q33750257-E2E1D753-662C-442C-B1F5-0C8CD6EFD090Q33752750-8685E9A7-6039-4D49-93EE-4D7812CF8F97Q33758073-3F696D0C-5B03-4351-9552-69737EE9B7C9Q33775443-F41A961B-AFB0-4355-A227-1A90D75F4094Q33784386-42656AD2-6EF6-4C5F-925E-58CE46BF9EECQ33792227-947E6B41-3365-4316-8CAA-FA1AC747EB8FQ33825642-FE50C7FE-B61B-4467-889F-C9CA1F9542C6Q33833442-6D105AD9-39DB-4EB7-8189-CD2488525094Q33856133-D9556372-3A7A-4740-ADD8-0C0F44397647Q33856228-5CF8A8A1-0E4A-4376-804E-DEA57B4E44ACQ33866775-C0E7812B-6C2D-48A9-BF05-1BE83C57AF6AQ33991178-AC3416DB-45B8-450E-85F4-5FAC4DABE5E6Q33998364-5A5FBD3C-A016-4F51-8249-B871F600DA1AQ34002019-219C49D7-EA67-4674-B50B-99A6FA8264D8Q34002283-97F395E6-F2FB-45F3-B1B6-70D8085C1D13Q34002672-0D793DB2-D4A3-40B9-B1C7-6B0C499D3CC6Q34003563-24D5F83A-3302-4621-A81C-1C597F644705Q34003893-6602852B-1CE3-4553-817D-512ABA5793FDQ34004892-D60E8A54-7EDC-46EA-A1EE-3E5834505B1AQ34008022-8BA93C38-25C4-4CBF-95C2-018A3F2D2B55Q34013394-4DDEF139-5E28-41CF-AF83-095F8444D1FB
P2860
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A controlled trial of a two-co ...... whole-cell pertussis vaccine.
@en
type
label
A controlled trial of a two-co ...... whole-cell pertussis vaccine.
@en
prefLabel
A controlled trial of a two-co ...... whole-cell pertussis vaccine.
@en
P2093
P1476
A controlled trial of a two-co ...... whole-cell pertussis vaccine.
@en
P2093
Gustafsson L
Hallander HO
Reizenstein E
Storsaeter J
P304
P356
10.1056/NEJM199602083340602
P407
P577
1996-02-01T00:00:00Z